rs86487

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_133642.5(LARGE1):​c.435C>T​(p.Ala145Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.484 in 1,612,472 control chromosomes in the GnomAD database, including 194,473 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A145A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.41 ( 14560 hom., cov: 32)
Exomes 𝑓: 0.49 ( 179913 hom. )

Consequence

LARGE1
NM_133642.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.0540

Publications

25 publications found
Variant links:
Genes affected
LARGE1 (HGNC:6511): (LARGE xylosyl- and glucuronyltransferase 1) This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018]
LARGE1 Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy-dystroglycanopathy type B6
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 22-33626300-G-A is Benign according to our data. Variant chr22-33626300-G-A is described in ClinVar as Benign. ClinVar VariationId is 95175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.054 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.567 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133642.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARGE1
NM_133642.5
MANE Select
c.435C>Tp.Ala145Ala
synonymous
Exon 4 of 15NP_598397.1O95461-1
LARGE1
NM_001362949.2
c.435C>Tp.Ala145Ala
synonymous
Exon 5 of 16NP_001349878.1O95461-1
LARGE1
NM_001362951.2
c.435C>Tp.Ala145Ala
synonymous
Exon 4 of 15NP_001349880.1O95461-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LARGE1
ENST00000397394.8
TSL:5 MANE Select
c.435C>Tp.Ala145Ala
synonymous
Exon 4 of 15ENSP00000380549.2O95461-1
LARGE1
ENST00000354992.7
TSL:1
c.435C>Tp.Ala145Ala
synonymous
Exon 5 of 16ENSP00000347088.2O95461-1
LARGE1
ENST00000402320.6
TSL:1
c.435C>Tp.Ala145Ala
synonymous
Exon 4 of 14ENSP00000385223.1O95461-2

Frequencies

GnomAD3 genomes
AF:
0.408
AC:
62024
AN:
151924
Hom.:
14551
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.522
Gnomad AMR
AF:
0.497
Gnomad ASJ
AF:
0.537
Gnomad EAS
AF:
0.584
Gnomad SAS
AF:
0.518
Gnomad FIN
AF:
0.524
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.490
Gnomad OTH
AF:
0.436
GnomAD2 exomes
AF:
0.488
AC:
122435
AN:
251030
AF XY:
0.492
show subpopulations
Gnomad AFR exome
AF:
0.154
Gnomad AMR exome
AF:
0.542
Gnomad ASJ exome
AF:
0.542
Gnomad EAS exome
AF:
0.572
Gnomad FIN exome
AF:
0.525
Gnomad NFE exome
AF:
0.488
Gnomad OTH exome
AF:
0.501
GnomAD4 exome
AF:
0.492
AC:
718511
AN:
1460430
Hom.:
179913
Cov.:
43
AF XY:
0.493
AC XY:
358346
AN XY:
726612
show subpopulations
African (AFR)
AF:
0.150
AC:
5036
AN:
33464
American (AMR)
AF:
0.533
AC:
23837
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.542
AC:
14148
AN:
26120
East Asian (EAS)
AF:
0.595
AC:
23609
AN:
39684
South Asian (SAS)
AF:
0.511
AC:
44055
AN:
86204
European-Finnish (FIN)
AF:
0.522
AC:
27873
AN:
53376
Middle Eastern (MID)
AF:
0.527
AC:
3042
AN:
5768
European-Non Finnish (NFE)
AF:
0.493
AC:
547475
AN:
1110782
Other (OTH)
AF:
0.488
AC:
29436
AN:
60328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
20143
40286
60428
80571
100714
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16008
32016
48024
64032
80040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.408
AC:
62037
AN:
152042
Hom.:
14560
Cov.:
32
AF XY:
0.411
AC XY:
30510
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.161
AC:
6674
AN:
41494
American (AMR)
AF:
0.497
AC:
7600
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.537
AC:
1864
AN:
3468
East Asian (EAS)
AF:
0.584
AC:
3012
AN:
5156
South Asian (SAS)
AF:
0.518
AC:
2491
AN:
4812
European-Finnish (FIN)
AF:
0.524
AC:
5525
AN:
10542
Middle Eastern (MID)
AF:
0.514
AC:
151
AN:
294
European-Non Finnish (NFE)
AF:
0.490
AC:
33315
AN:
67972
Other (OTH)
AF:
0.440
AC:
930
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1693
3386
5080
6773
8466
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.452
Hom.:
35614
Bravo
AF:
0.398
Asia WGS
AF:
0.518
AC:
1802
AN:
3478
EpiCase
AF:
0.507
EpiControl
AF:
0.506

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
3
not provided (3)
-
-
2
Muscular dystrophy-dystroglycanopathy type B6 (2)
-
-
1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
13
DANN
Benign
0.79
PhyloP100
-0.054
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs86487; hg19: chr22-34022284; COSMIC: COSV61657973; API